The effective shelf allows Alpha Capital Anstalt to convert and sell shares at any time, creating persistent overhang. With only $2.2M cash and a working capital deficit, the company may need further financing, compounding dilution. Traders should monitor for any Form 4 filings indicating conversion and sale by Alpha Capital.
Price Chart
Executive Summary
ENvue Medical's S-3 registration statement (File No. 333-296001) became effective on May 28, 2026. This shelf registration covers the resale of up to 6,000,768 shares of common stock issuable upon conversion of Series H Convertible Preferred Stock held by sole institutional investor Alpha Capital Anstalt. The company receives no proceeds from this resale, and the effectiveness introduces immediate dilution overhang for existing common shareholders.
Key Facts
- S-3 registration (File No. 333-296001) declared effective May 28, 2026
- Registration covers 6,000,768 shares of common stock for resale by Alpha Capital Anstalt
- Shares are issuable upon conversion of Series H Convertible Preferred Stock
- Company will not receive any proceeds from this resale registration
- Prior S-3 filing (May 18, 2026) noted cash of $2.2M, working capital deficit, and accumulated deficit as of Q1 2026
- Market cap is approximately $6M, making the registered shares a significant portion of outstanding equity
Financial Impact
Up to 6,000,768 shares registered for resale against a ~$6M market cap — potential dilution of over 100% of current float if all shares are converted and sold
Risk Factors
- Immediate dilution risk from potential conversion and resale of 6M+ shares
- Company's precarious cash position ($2.2M) raises going-concern risk
- No proceeds to company from this resale — no benefit to offset dilution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001794 |
| Document: 9999999995-26-001794-index.html | 9999999995-26-001794 |
| Document: 9999999995-26-001794.txt | 9999999995-26-001794 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 11d ago | 8-K | $0.4900 | awaiting T+20 | — | $0.2500 (+48.98%) |
Sep 4, 2026 7w ago | EFFECT | $4.03 $1.03 | ▲ +74.44% | ▲ +75.04% | $0.2500 (+93.80%) |
Aug 31, 2026 7w ago | 8-K | $4.31 | awaiting T+20 | — | $0.2500 (−94.20%) |
Aug 12, 2026 10w ago | 8-K | $4.90 $3.57 | ▲ +27.08% | ▲ +25.19% | $0.2500 (+94.89%) |
Aug 10, 2026 10w ago | S-3 | $0.3982 $0.3033 | ▲ +23.82% | ▲ +22.76% | $0.2500 (+37.22%) |
Jul 10, 2026 15w ago | 8-K | $0.4578 $0.4140 | ▲ +9.57% | ▲ +12.75% | $0.2500 (+45.39%) |
Jun 3, 2026 20w ago | Press Release | $0.8600 $0.5200 | ▼ −39.53% | ▼ −38.53% | $0.2500 (−70.93%) |
May 29, 2026 21w ago | EFFECT | $0.9020 $0.5400 | ▲ +40.13% | ▲ +38.34% | $0.2500 (+72.28%) |
May 18, 2026 22w ago | S-3 | $0.9300 $0.7262 | ▲ +21.91% | ▲ +22.90% | $0.2500 (+73.12%) |
May 12, 2026 23w ago | Press Release | $1.24 $0.8530 | ▼ −31.21% | ▼ −29.48% | $0.2500 (−79.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers